跳至主要内容
临床试验/ACTRN12615000346572
ACTRN12615000346572招募中不适用

Safety and efficacy of fluoroscopic guided modified single needle trans-discal approach for neurolytic retrocrural celiac plexus block in patients with inoperable upper gastrointestinal cancer pain

Tanta University0 个研究点目标入组 30 人开始时间: 2015年4月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1- Thirty patients have inoperable upper gastrointestinal tumors including (cancer lower third esophagus, stomach, pancreas, biliary tract).
  • 2- With uncontrolled visceral pain (Visual analogue scale greater than or equal to 7/10).
  • 3- With maximum tolerable dose of opioids.

排除标准

  • 1-Patients have coagulopathy.
  • 2- Patients have local infection at the area of needle insertion.
  • 3- Decompensate cardiac disorders.
  • 4- Hemodynamic instability.
  • 5- Radiological evident metastatic lesions.
  • 6- Psychiatric disorders affecting cooperation.
  • 7- Has undergone previous blocks affecting severity of the present pain.

研究者

相似试验